Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:16 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 2,674 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Stanford University Clear all

Conditions: Bone Cancer, Chondrosarcoma, Ewing's Sarcoma, Osteosarcoma, Rhabdomyosarcoma, Bone Necrosis, Bone Sarcoma, Osteomyelitis
Interventions: Feraheme, Magnetic Resonance Imaging (MRI) scan; Drug · Procedure
Lead sponsor: Heike E Daldrup-Link; Other
Eligibility: 10 Years to 21 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Sinusitis, Opioid Use, Opioid Abuse, Narcotic Use, Otolaryngologic Disease, Postoperative Pain, Pain
Interventions: OxyCODONE 5 Mg (milligram) Oral Tablet, Ibuprofen 600 Mg (milligram) Oral Tablet, Acetaminophen 650 MG (milligram) Oral Tablet; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 5
States / cities: Stanford, California • Evanston, Illinois • Rochester, Minnesota + 2 more

Conditions: Covid19
Interventions: Filtration Fan, Safe-home pamphlet, Mid-week phone call; Device · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: Not listed
Enrollment: 214 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: San Mateo, California • Stanford, California

Conditions: Depression in Adolescence, Delayed Sleep Phase
Interventions: TranS-C, Psychoeducation; Behavioral
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 12 Years to 18 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast - Female
Interventions: Transversus Abdominis Plane (TAP) block, Nimbus Infusion Pump IV Administration, Bupivacaine infusion, Acetominophen, Hydromorphone, Oxycodone, Ondansetron; Procedure · Device · Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Colon Ischemia, Aortic Aneurysm
Interventions: Reestablish colon blood flow; Procedure
Lead sponsor: Spectros Corporation; Industry
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Davis, California • Palo Alto, California

Conditions: Myeloproliferative Disorders, Blood Cancer, Myelodysplastic Syndromes
Interventions: Total Lymphoid Irradiation (TLI), Anti-Thymocyte Globulin as Conditioning (ATG); Procedure
Lead sponsor: Stanford University; Other
Eligibility: 49 Years to 75 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2015
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pain
Interventions: Drug Dose; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Stanford, California

Conditions: Solid Tumor, Central Nervous System Tumor, Lymphoma, Leukemia
Interventions: Neratinib; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 3 Years to 21 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 8
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Palo Alto, California + 5 more

Conditions: Food Allergy
Interventions: Xolair, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 4 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Mountain View, California

Conditions: Hoarding Disorder, Hoarding, Clutter
Interventions: Facilitated group therapy with behavioral practice; 16 weeks; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 56 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Hyperoxia, Hypoxia
Interventions: Computer-assisted Oxygen Weaning; Device
Lead sponsor: Stanford University; Other
Eligibility: Up to 2 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Prostate Cancer, Prostatic Neoplasms, Castrate-resistant Prostate Cancer (CRPC), Androgen-insensitive Prostate Cancer, Hormone-refractory Prostate Cancer, Metastatic Disease
Interventions: Temsirolimus, Casodex (bicalutamide); Drug
Lead sponsor: Sandy Srinivas; Other
Eligibility: 18 Years and older · Male only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Myopia, Astigmatism
Interventions: Photorefractive keratectomy, Laser in-situ keratomileusis; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 21 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Stanford, California

Conditions: Convulsion, Non-Epileptic, Conversion Disorder, Depression, Stress Disorders, Post-Traumatic, Dissociative Disorders
Interventions: sertraline, CBT-ip, Combined (sertraline + CBT-ip), Standard Care; Drug · Behavioral · Other
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years to 95 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 3
States / cities: Stanford, California • Cincinnati, Ohio • Providence, Rhode Island

Conditions: Cardiovascular Risk Factor, Insulin Resistance, PreDiabetes, Diabetes, Coronary Artery Disease, Hypertension, Prehypertension, Dyslipidemias
Interventions: Use of HealthPals (Telemedicine supported by digital health platform); Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Brain Cancer
Interventions: Arsenic Trioxide, Stereotactic radiosurgery; Drug · Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Stanford, California

Conditions: Covid19
Interventions: Acebilustat, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Primary Sclerosing Cholangitis
Interventions: Hymecromone; Drug
Lead sponsor: Aparna Goel; Other
Eligibility: 14 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Redwood City, California • Stanford, California

Conditions: Food Allergy
Interventions: Omalizumab, Food Flour Allergens; Drug
Lead sponsor: Andrew Long, PharmD; Other
Eligibility: 2 Years to 25 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Los Angeles, California • Mountain View, California

Conditions: Advanced Malignant Solid Neoplasm, Extracranial Solid Neoplasm, Metastatic Malignant Solid Neoplasm
Interventions: Anti-OX40 Antibody BMS 986178, TLR9 Agonist SD-101; Biological · Drug
Lead sponsor: Ronald Levy; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Stroke, Acute
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 187 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 4
States / cities: Castro Valley, California • Stanford, California • Pittsburgh, Pennsylvania + 1 more

Conditions: Physical Activity
Interventions: EE Training; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 10 Years to 17 Years
Enrollment: 318 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Irvine, California

Conditions: Esophageal Spasm
Interventions: Magnesium sulfate, Normal Saline; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Stanford, California

Search by objective public record fields.

Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

Pain Control Following Sinus Surgery

Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes

Better Sleep Study

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair

TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD

Influence of Patient Choice of Intrathecal Morphine on Post-cesarean Delivery Pain.

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients

Hoarding Disorder Treatment With Virtual Reality

Computer-assisted Oxygen Therapy Weaning in Critically Ill Children

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Wavefront-guided Photorefractive Keratectomy (PRK) Versus Wavefront-guided Lasik for Myopia

Treatment Trial for Psychogenic Nonepileptic Seizures

Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology

Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol

Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.

Multi OIT to Test Immune Markers After Minimum Maintenance Dose

SD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid Malignancies

Imaging Collaterals in Acute Stroke (iCAS)

Molecular Transducers of Physical Activity Consortium (MoTrPAC) - Pediatric Protocol

Magnesium for Peroral Endoscopic Myotomy